Related Experiment Video
Updated: Jul 31, 2026
14:06
Rapid Testing of Resistance of Timber to Biodegradation by Marine Wood-Boring Crustaceans
Published on: January 29, 2022
Quality requirements for biocides in the 1990s
E D Weiler1, M A Jayjock, D E Greenley
1Rohm and Haas Company, Product Integrity Department, Philadelphia, Pennsylvania 19105.
Quality Assurance (San Diego, Calif.)
|September 1, 1993
Summary
New biocides face stringent quality standards, impacting development timelines and market entry. Companies are prioritizing existing product lifecycles due to these evolving regulatory and consumer demands.
Area of Science:
- Environmental Science
- Toxicology
- Regulatory Affairs
Background:
- Increasing regulatory and consumer safety expectations are reshaping the biocide industry.
- Product efficacy, toxicology, and risk assessment present significant hurdles for new biocides.
Purpose of the Study:
- To outline recent activities related to biocide quality standards.
- To analyze the impact of these standards on biocide marketing and development.
Main Methods:
- Review of current regulatory landscapes.
- Analysis of industry trends in biocide research and development.
- Examination of product stewardship practices.
Main Results:
- Extended lead times for new biocide development.
- Limited new market entrants due to high quality barriers.
- Increased focus on extending the lifecycle of existing biocide products.
Conclusions:
- Biocide market entry is increasingly challenging due to rigorous quality and safety demands.
- Product stewardship and comprehensive risk management are critical for successful biocide marketing.
- Strategic adaptation to regulatory pressures is essential for future biocide innovation and commercialization.
Related Concept Videos
01:13Bioequivalence studies: Biowaivers
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
01:28Drug Products: Biologics, Biosimilars and Interchangeables
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
01:29Clinically Relevant Drug Product Specifications: Methods of Establishment
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
01:28Biological Methods for Microbial Control
Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
01:28Microbial Bioremediation of Pesticides
Pesticides often feature structurally complex chemical architectures, incorporating halogen groups and multiple aromatic rings. These characteristics confer high chemical stability, rendering many pesticides resistant to natural degradation processes. This resistance poses significant environmental concerns, as persistent pesticide residues can accumulate in ecosystems and affect non-target organisms.Despite the inherent stability of many pesticides, certain microorganisms possess the metabolic...
01:26Good Manufacturing Practices
Good Manufacturing Practices (GMP) constitute a foundational set of guidelines that ensure the production of safe, consistent, and high-quality products, particularly in industries such as pharmaceuticals, biotechnology, and food processing. These protocols encompass all aspects of production, from the sourcing of raw materials to the final distribution of the finished product.A core pillar of GMP is stringent hygiene and sanitation across all production environments. This includes routine...